An open label, dose titration study of sevelamer carbonate tablets dosed three times a day in hyperphosphatemic chronic kidney disease patients not on dialysis

Mise à jour : Il y a 4 ans
Référence : EUCTR2005-003233-41

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

- Evaluate the efficacy of sevelamer carbonate tablets dosed three times a day (TID) with meals on control of serum phosphorus levels - Evaluate the safety and tolerability of sevelamer carbonate tablets dosed TID with meals


Critère d'inclusion

  • chronic kidney disease